Atrial Fibrillation: An Overview on Abnormal Rapid Heart Rhythm

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
J. Marcus Wharton, MD, director of clinical cardiac electrophysiology at the Medical University of South Carolina, talks about the symptoms, causes, and consequences of atrial fibrillation.

To listen to this podcast, click here.
Related Articles
Non-vitamin K antagonist oral anticoagulants are increasingly being prescribed to prevent and treat venous thromboembolism and avert stroke in patients with atrial fibrillation.
Six patient deaths and other serious adverse events have been linked to SentreHeart’s Lariat Suture Delivery Device, the FDA is warning health care professionals.
Here are new drugs for 2015 that pharmacists can expect to handle.
A practice-changing study suggests bridging anticoagulation does more harm than good in atrial fibrillation (AF) patients treated with warfarin.
Latest Issues
$auto_registration$